Advocacy intelligence hub — real-time data for patient organizations
Massachusetts General Hospital — PHASE1
University Hospital, Rouen — PHASE3
AstraZeneca — PHASE1, PHASE2
Eilean Therapeutics — PHASE1
Tasca Therapeutics — PHASE1, PHASE2
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Arizona State University — NA
PedAL BCU, LLC — PHASE1
Alterome Therapeutics, Inc. — PHASE1
University Ghent — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Nancy D. Perrier, MD, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Use Central Contact
Astellas Pharma Inc
Susan Peterson, PhD
M.D. Anderson Cancer Center
Joan L Bottorff
University of British Columbia
Diana Blithe
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Glenda Courtney-Martin, BSc
The Hospital for Sick Children